ASND vs. FINV
ASND (Ascendis Pharma A/S) and FINV (FinVolution Group) are both stocks. ASND operates in Biotechnology (Healthcare), while FINV operates in Credit Services (Financial Services). Over the past 5 years, ASND returned 16.50%/yr vs -5.82%/yr for FINV. At a 0.17 correlation, their price movements are largely independent.
Performance
ASND vs. FINV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ASND achieves a 26.83% return, which is significantly higher than FINV's -7.69% return.
ASND
- 1D
- -1.81%
- 1M
- 24.03%
- 6M
- 33.23%
- YTD
- 26.83%
- 1Y
- 54.58%
- 3Y*
- 45.40%
- 5Y*
- 16.50%
- 10Y*
- 35.49%
FINV
- 1D
- -4.42%
- 1M
- -9.74%
- 6M
- -3.63%
- YTD
- -7.69%
- 1Y
- -54.45%
- 3Y*
- 1.97%
- 5Y*
- -5.82%
- 10Y*
- —
ASND vs. FINV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | 26.83% | 54.89% | 9.31% | 3.13% | -9.22% | -19.34% | 19.88% | 122.06% | 56.39% | 13.26% |
FINV FinVolution Group | -7.69% | -20.07% | 45.47% | 4.39% | 6.39% | 89.23% | 8.51% | -22.85% | -49.37% | -46.54% |
Correlation
The correlation between ASND and FINV is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Nov 10, 2017 | 0.17 |
Fundamentals
ASND:
$16.80B
FINV:
$1.13B
ASND:
€8.13
FINV:
CN¥8.34
ASND:
29.12
FINV:
3.69
ASND:
0.13
FINV:
1.29
ASND:
17.01
FINV:
0.61
ASND:
31.28
FINV:
0.49
ASND:
€867.51M
FINV:
CN¥13.24B
ASND:
€764.89M
FINV:
CN¥10.21B
ASND:
-€6.94M
FINV:
CN¥2.61B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASND vs. FINV — Risk / Return Rank
ASND
FINV
ASND vs. FINV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and FinVolution Group (FINV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASND | FINV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.52 | ||
| Sortino ratioReturn per unit of downside risk | +3.88 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 0.79 | +0.46 |
| Calmar ratioReturn relative to maximum drawdown | 3.08 | -0.95 | +4.03 |
| Martin ratioReturn relative to average drawdown | 9.35 | -1.21 | +10.56 |
Loading charts...
Drawdowns
ASND vs. FINV - Drawdown Comparison
The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum FINV drawdown of -89.76%. Use the drawdown chart below to compare losses from any high point for ASND and FINV.
Loading charts...
Drawdown Indicators
| ASND | FINV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.72% | -89.76% | +28.04% |
Max Drawdown (1Y)Largest decline over 1 year | -17.62% | -56.42% | +38.80% |
Max Drawdown (3Y)Largest decline over 3 years | -29.15% | -56.42% | +27.27% |
Max Drawdown (5Y)Largest decline over 5 years | -60.46% | -63.30% | +2.84% |
Max Drawdown (10Y)Largest decline over 10 years | -61.72% | — | — |
Current DrawdownCurrent decline from peak | -2.43% | -54.45% | +52.02% |
Average DrawdownAverage peak-to-trough decline | -18.80% | -54.07% | +35.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.77% | 43.95% | -38.18% |
Volatility
ASND vs. FINV - Volatility Comparison
Ascendis Pharma A/S (ASND) has a higher volatility of 12.40% compared to FinVolution Group (FINV) at 9.75%. This indicates that ASND's price experiences larger fluctuations and is considered to be riskier than FINV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ASND | FINV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.40% | 9.75% | +2.65% |
Volatility (6M)Calculated over the trailing 6-month period | 29.75% | 33.79% | -4.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.20% | 48.68% | -10.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.85% | 49.30% | -0.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.09% | 71.52% | -20.43% |
Dividends
ASND vs. FINV - Dividend Comparison
ASND has not paid dividends to shareholders, while FINV's dividend yield for the trailing twelve months is around 6.74%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FINV FinVolution Group | 6.74% | 5.30% | 3.49% | 4.39% | 4.13% | 3.45% | 4.49% | 7.17% |
Financials
ASND vs. FINV - Financials Comparison
This section allows you to compare key financial metrics between Ascendis Pharma A/S and FinVolution Group. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ASND and FINV have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ASND has higher volatility (12.40%) compared to FINV (9.75%). In terms of maximum drawdown, ASND dropped -61.72% vs FINV's -89.76%.
ASND currently has the higher Sharpe Ratio (1.42 vs -1.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ASND and FINV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer